Cargando…
Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic
Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of p...
Autores principales: | Dassarma, Barsha, Tripathy, Satyajit, Matsabisa, Motlalepula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718590/ https://www.ncbi.nlm.nih.gov/pubmed/33285298 http://dx.doi.org/10.1016/j.tracli.2020.11.004 |
Ejemplares similares
-
A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic
por: Tripathy, Satyajit, et al.
Publicado: (2020) -
Challenges in Establishing Vaccine Induced Herd Immunity through Age Specific Community Vaccinations
por: Dassarma, Barsha, et al.
Publicado: (2022) -
Study on South African Indigenous Teas—Antioxidant Potential, Nutritional Content, and Hypoxia-Induced Cyclooxygenase Inhibition on U87 MG Cell Line
por: Matsabisa, Motlalepula Gilbert, et al.
Publicado: (2022) -
Convalescent plasma (CP) therapy in patients with COVID-19
por: Cakir, Banu
Publicado: (2021) -
Quality Related Safety Evaluation of a South African Traditional Formulation (PHELA(®)) as Novel Anti-Biofilm Candidate
por: Das, Bhaskar, et al.
Publicado: (2022)